Starting, Choosing, Changing, and Discontinuing Drug Treatment for Epilepsy Patients
- 1 May 2016
- journal article
- review article
- Published by Elsevier in Neurologic Clinics
- Vol. 34 (2) , 363-381
- https://doi.org/10.1016/j.ncl.2015.11.007
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia, 2013
- Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyThe Lancet Neurology, 2013
- Patterns of treatment response in newly diagnosed epilepsyNeurology, 2012
- Ezogabine: A New Angle on Potassium GatesEpilepsy Currents, 2011
- Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence EpilepsyNew England Journal of Medicine, 2010
- Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsyBrain, 2008
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind studyThe Lancet, 1999
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985